Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Clinical Chemistry and Laboratory Medicine|April 2, 2024
IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosisLars Hagberg, Igal Rosenstein, Jan Lycke, et al.
Annals of Clinical and Translational Neurology|June 17, 2022
SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorderMagnus Johnsson, Fredrik Asztely, Susanne Hejnebo, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2006
The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatmentAnders Helldén, Jan Lycke, Tatiana Vander, et al.
Acta Neurologica Scandinavica|January 19, 2019
Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapiesMarkus Axelsson, Nicolas Dubuisson, Lenka Novakova, et al.
Frontiers in Neurology|October 9, 2023
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosisSofia Sandgren, Lenka Novakova, Anna Nordin, et al.
Journal of Neurology|June 14, 2023
Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosisIgal Rosenstein, Markus Axelsson, Lenka Novakova, et al.
Neuroepidemiology|August 29, 2015
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple SclerosisMaria Kneider, Vera Lisovskaja, Jan Lycke, et al.
Multiple Sclerosis and Related Disorders|May 8, 2021
Persons with suspicious onset of multiple sclerosis but with undetermined diagnosis had persistent lower cognition and reduced quality of lifeClara Constantinescu, Lenka Novakova, Anne Frandsen Brandt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 20, 2022
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumabMagnus Johnsson, Helen H Farman, Kaj Blennow, et al.
Journal of the Neurological Sciences|October 25, 2016
Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29Claudio Gasperini, Raymond Hupperts, Jan Lycke, et al.
Pageof 12